PAPER Morbey H, Harding AJ, Swarbrick C, Ahmed F, Elvish R, Keady J, Williamson PR, Reilly ST

Involving people living with dementia in research: an accessible modified Delphi survey for core outcome set development.

Trials. 2019 Jan 6;20(1):12. PubMed.

PAPER Zhang K, Wang J, Peng G, Liu P, He F, Zhu Z, Luo B

Effect of cognitive training on episodic memory retrieval in amnestic mild cognitive impairment patients: study protocol for a clinical randomized controlled trial.

Trials. 2019 Jan 8;20(1):26. PubMed.

PAPER Regan J, Frison E, Collin F, Dawes P, Hann M, Himmelsbach I, Hooper E, Reeves D, Simkin Z, Thodi C, Yang F, Leroi I, SENSE-Cog Trial Development Team

Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial.

Trials. 2019 Jan 25;20(1):80. PubMed.

PAPER Marlats F, Djabelkhir-Jemmi L, Azabou E, Boubaya M, Pouwels S, Rigaud AS

Comparison of effects between SMR/delta-ratio and beta1/theta-ratio neurofeedback training for older adults with Mild Cognitive Impairment: a protocol for a randomized controlled trial.

Trials. 2019 Jan 29;20(1):88. PubMed.

PAPER Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Harrison J, Brooks DJ, Passmore AP, Ballard C, Edison P

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).

Trials. 2019 Apr 3;20(1):191. PubMed. Correction.

PAPER Belleville S, Moussard A, Ansaldo AI, Belchior P, Bherer L, Bier N, Bohbot VD, Bruneau MA, Cuddy LL, Gilbert B, Jokel R, Mahalingam K, McGilton K, Murphy KJ, Naglie G, Rochon E, Troyer AK, Anderson ND

Rationale and protocol of the ENGAGE study: a double-blind randomized controlled preference trial using a comprehensive cohort design to measure the effect of a cognitive and leisure-based intervention in older adults with a memory complaint.

Trials. 2019 May 22;20(1):282. PubMed.

PAPER Cave AE, Chang DH, Münch GW, Steiner GZ

Efficacy of Cognition Support Formula® on cognitive function in older adults with subjective cognitive impairment: a protocol for a 26-week, randomised, double-blind, placebo-controlled trial.

Trials. 2019 Jun 10;20(1):345. PubMed.

PAPER Shin HY, Kim JH, Jahng GH, Jung WS, Park SU, Ko CN, Park JM

The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial.

Trials. 2019 Jul 22;20(1):448. PubMed.

PAPER Yue S, He T, Li B, Qu Y, Peng H, Chen J, Lei M, Chen C, Wu W

Effectiveness of Yi-Zhi-An-Shen granules on cognition and sleep quality in older adults with amnestic mild cognitive impairment: protocol for a randomized, double-blind, placebo-controlled trial.

Trials. 2019 Aug 20;20(1):518. PubMed.

PAPER Kim JH, Cho MR, Park GC, Lee JS

Effects of different acupuncture treatment methods on mild cognitive impairment: a study protocol for a randomized controlled trial.

Trials. 2019 Sep 4;20(1):551. PubMed.

PAPER Moga DC, Beech BF, Abner EL, Schmitt FA, El Khouli RH, Martinez AI, Eckmann L, Huffmyer M, George R, Jicha GA

INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer's Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol.

Trials. 2019 Dec 30;20(1):806. PubMed.

PAPER Li D, Mielke MM, Bell WR, Reilly C, Zhang L, Lin FV, Yu F

Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial).

Trials. 2020 Jan 6;21(1):19. PubMed.

PAPER Griffiths S, Manger L, Chapman R, Weston L, Sherriff I, Quinn C, Clarkson P, Sutcliffe C, Davies K, Byng R

Letter on "Protection by exclusion? The (lack of) inclusion of adults who lack capacity to consent to research in clinical trials in the UK".

Trials. 2020 Jan 21;21(1):104. PubMed.

PAPER Fowler NR, Head KJ, Perkins AJ, Gao S, Callahan CM, Bakas T, Suarez SD, Boustani MA

Examining the benefits and harms of Alzheimer's disease screening for family members of older adults: study protocol for a randomized controlled trial.

Trials. 2020 Feb 19;21(1):202. PubMed.

PAPER Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Harrison J, Hölscher C, Brooks DJ, Passmore AP, Ballard C, Edison P

Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).

Trials. 2020 Jul 19;21(1):660. PubMed.